weight-loss drug | BeyondLINK

Business ThePostMaster - December 23, 2025

Ajanta Pharma has entered into an in-licensing agreement with Biocon for Semaglutide.Under the agreement, Biocon will supply Semaglutide...

Finance ThePostMaster - December 22, 2025

The pole position in the GLP-1 weight loss space is currently...

Finance ThePostMaster - December 12, 2025

Eli Lilly is currently the leader in the GLP-1 weight loss...

Health ThePostMaster - December 2, 2025

Finance ThePostMaster - November 13, 2025

Eli Lilly and Company (NYSE:LLY) is one of the stocks Jim Cramer offered insights on. Cramer...

Finance ThePostMaster - November 7, 2025

Novo Nordisk reported Q3 2025 earnings on November 5, showing continued strong demand for its weight-loss...

Personal Finance ThePostMaster - November 1, 2025

Preethi: Dr Reddy’s stock was down 4 per cent on Thursday as Health Canada issued a notice of...

Finance ThePostMaster - October 1, 2025

The weight-loss drug market has exploded into one of the fastest-growing markets in recent years. Novo...

Enertain ThePostMaster - August 6, 2025

Novo Nordisk (NVO) stock was down pre-market after the company missed on top and bottom lines...

Tag: weight-loss drug